JP2017214420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017214420A5 JP2017214420A5 JP2017159116A JP2017159116A JP2017214420A5 JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5 JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017159116 A JP2017159116 A JP 2017159116A JP 2017214420 A5 JP2017214420 A5 JP 2017214420A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- composition
- dash inhibitor
- group
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161562497P | 2011-11-22 | 2011-11-22 | |
| US61/562,497 | 2011-11-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Division JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017214420A JP2017214420A (ja) | 2017-12-07 |
| JP2017214420A5 true JP2017214420A5 (cg-RX-API-DMAC7.html) | 2018-02-08 |
Family
ID=48470210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
| JP2017159116A Pending JP2017214420A (ja) | 2011-11-22 | 2017-08-22 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543501A Active JP6240083B2 (ja) | 2011-11-22 | 2012-11-15 | 樹状細胞癌ワクチンのための小分子エンハンサー |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9284337B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2782994B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6240083B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN106075450A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2012340887A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2856379A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1201871A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL232664A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013078059A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9284337B2 (en) * | 2011-11-22 | 2016-03-15 | Trustees Of Tufts College | Small molecule enhancer for dendritic cell cancer vaccines |
| WO2016085943A1 (en) | 2014-11-25 | 2016-06-02 | Rastelli, Luca | Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2 |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| US11000521B2 (en) | 2015-08-03 | 2021-05-11 | Institut Pasteur | Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy |
| WO2018049027A1 (en) * | 2016-09-07 | 2018-03-15 | Trustees Of Tufts College | Combination therapies using immuno-dash inhibitors and pge2 antagonists |
| US11040027B2 (en) | 2017-01-17 | 2021-06-22 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| US11559537B2 (en) | 2017-04-07 | 2023-01-24 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists |
| WO2018187698A2 (en) * | 2017-04-07 | 2018-10-11 | Trustees Of Tufts College | Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists |
| JP2019208422A (ja) * | 2018-06-04 | 2019-12-12 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040145A (en) * | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| CA2339537A1 (en) * | 1998-08-21 | 2000-03-02 | Barbara Wallner | Regulation of substrate activity |
| HK1046846A1 (zh) | 1999-05-25 | 2003-01-30 | Point Therapeutics, Inc. | 包含boroproline的抗肿瘤复合物 |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| CN100392074C (zh) * | 2003-10-15 | 2008-06-04 | 上海海欣生物技术有限公司 | 树突状细胞肿瘤疫苗及其制法和用途 |
| CN101247799B (zh) * | 2005-07-05 | 2013-03-27 | 塔夫茨大学信托人 | 成纤维细胞活化蛋白α的抑制剂 |
| CN101379069A (zh) * | 2005-12-19 | 2009-03-04 | 塔夫茨大学信托人 | 软蛋白酶抑制剂及其前软形式 |
| WO2007123686A2 (en) * | 2006-03-31 | 2007-11-01 | Point Therapeutics, Inc. | Dpp inhibitors and uses thereof |
| CA2681351A1 (en) * | 2007-03-20 | 2008-09-25 | Trustees Of Tufts College | Inhibitors of fibroblast activation protein, and methods of use thereof |
| EP2154243B1 (en) * | 2007-05-17 | 2016-01-13 | ID Pharma Co., Ltd. | Method for production of dendritic cell |
| JP5721441B2 (ja) * | 2008-01-31 | 2015-05-20 | キュアバック ゲーエムベーハーCurevac Gmbh | 免疫賦活剤/アジュバントとしての式(I)(NuGlXmGnNv)aで表される核酸分子及びその誘導体 |
| US9284337B2 (en) * | 2011-11-22 | 2016-03-15 | Trustees Of Tufts College | Small molecule enhancer for dendritic cell cancer vaccines |
-
2012
- 2012-11-15 US US14/353,408 patent/US9284337B2/en active Active
- 2012-11-15 EP EP12850873.6A patent/EP2782994B1/en active Active
- 2012-11-15 JP JP2014543501A patent/JP6240083B2/ja active Active
- 2012-11-15 AU AU2012340887A patent/AU2012340887A1/en not_active Abandoned
- 2012-11-15 CN CN201610493117.7A patent/CN106075450A/zh active Pending
- 2012-11-15 WO PCT/US2012/065236 patent/WO2013078059A1/en not_active Ceased
- 2012-11-15 EP EP16180971.0A patent/EP3106173A1/en not_active Withdrawn
- 2012-11-15 CN CN201280067478.5A patent/CN104039952A/zh active Pending
- 2012-11-15 HK HK15102280.8A patent/HK1201871A1/xx unknown
- 2012-11-15 CA CA2856379A patent/CA2856379A1/en not_active Abandoned
-
2014
- 2014-05-18 IL IL232664A patent/IL232664A0/en unknown
-
2015
- 2015-11-23 US US14/948,777 patent/US9839646B2/en active Active
-
2017
- 2017-08-22 JP JP2017159116A patent/JP2017214420A/ja active Pending
- 2017-11-20 US US15/817,754 patent/US20180092933A1/en not_active Abandoned
-
2018
- 2018-06-25 AU AU2018204591A patent/AU2018204591A1/en not_active Abandoned